125 related articles for article (PubMed ID: 14037855)
1. Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxy-isobutyrate.
THROP JM
Lancet; 1962 Jun; 1(7243):1323-6. PubMed ID: 14037855
[No Abstract] [Full Text] [Related]
2. REDUCTION OF SERUM TRIGLYCERIDES AND CHOLESTEROL BY ETHYL P-CHLOROPHENOXY-ISOBUTYRATE (CPIB).
BEST MM; DUNCAN CH
Am J Cardiol; 1965 Feb; 15():230-3. PubMed ID: 14254816
[No Abstract] [Full Text] [Related]
3. Effect of anabolic steroids on liver function tests and creatine excretion.
MARQUARDT GH; FISHER CI; LEVY P; DOWBEN RM
JAMA; 1961 Mar; 175():851-3. PubMed ID: 13767058
[No Abstract] [Full Text] [Related]
4. Reduction of serum-lipid and uric-acid levels by an orally active androsterone.
OLIVER MF
Lancet; 1962 Jun; 1(7243):1321-3. PubMed ID: 14481816
[No Abstract] [Full Text] [Related]
5. EFFECTS OF ALPHA-P-CHLOROPHENOXYISOBUTYRYL ETHYL ESTER (CPIB) WITH AND WITHOUT ANDROSTERONE ON CHOLESTEROL BIOSYNTHESIS IN RAT LIVER.
AVOY DR; SWYRYD EA; GOULD RG
J Lipid Res; 1965 Jul; 6():369-76. PubMed ID: 14336208
[No Abstract] [Full Text] [Related]
6. THE EFFECTS OF CHLOROPHENOXYISOBUTYRATE WITH AND WITHOUT ANDROSTERONE ON THE SERUM LIPIDS, FAT TOLERANCE, AND URIC ACID.
BERKOWITZ D
Metabolism; 1965 Sep; 14():966-75. PubMed ID: 14327273
[No Abstract] [Full Text] [Related]
7. HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.
BEST MM; DUNCAN CH
J Lab Clin Med; 1964 Oct; 64():634-42. PubMed ID: 14233152
[No Abstract] [Full Text] [Related]
8. [TREATMENT OF LIPID METABOLISM DISORDERS WITH ETHYL ALPHA-(P-CHLOROPHENOXY)-ISOBUTYRATE].
WAGENER H; FROSCH B
Med Klin; 1964 Nov; 59():1872-5. PubMed ID: 14331763
[No Abstract] [Full Text] [Related]
9. EFFECT OF ETHYL CHLOROPHENOXYISOBUTYRATE WITH OR WITHOUT ANDROSTERONE ON PLATELET STICKINESS.
SYMONS C; DETOSZEGHI A; COOK IJ
Lancet; 1964 Aug; 2(7353):233-4. PubMed ID: 14163151
[No Abstract] [Full Text] [Related]
10. Urinary excretion patterns for substances with simultaneous secretion and reabsorption by active transport.
BERGLUND F
Acta Physiol Scand; 1961; 52():276-90. PubMed ID: 13867726
[No Abstract] [Full Text] [Related]
11. [CHOLESTEROL AND BLOOD LIPID BEHAVIOR IN ARTERIOSCLEROSIS UNDER THE EFFECTS OF PROTECTED ANDROSTERONE (ATROMID)].
MARIN R; GARCIAFERNANDEZ JL; GARCIAOTERO V; RODRIGUEZPUCHOL J; PESCADOR L
Rev Esp Cardiol; 1964 Jul; 17():563-73. PubMed ID: 14232044
[No Abstract] [Full Text] [Related]
12. THE EFFECT OF ATROMID AND ETHYL CHLOROPHENOXYISOBUTYRATE ON THE EXCRETION OF URIC ACID. A PRELIMINARY REPORT.
TREVAKS G; LOVELL RR
J Atheroscler Res; 1963; 3():725. PubMed ID: 14100918
[No Abstract] [Full Text] [Related]
13. [Action of dextro-thyroxine and androsterone on blood cholesterol and coagulation factors in atherosclerosis].
DUFAULT C; TREMBLAY G; NOWACZYNSKI W; GENEST J
Union Med Can; 1961 Dec; 90():1351-64. PubMed ID: 13888219
[No Abstract] [Full Text] [Related]
14. Metabolic effects of dehydroepiandrosterone and Atromid in patients with hyperlipaemia.
Felt V; Stárka L
Cor Vasa; 1966; 8(1):40-8. PubMed ID: 4160021
[No Abstract] [Full Text] [Related]
15. Influence of dextro-thyroxine and androsterone on blood clotting factors and serum cholesterol in patients with atherosclerosis.
DUFAULT C; TREMBLAY G; NOWACZYNSKI W; GENEST J
Can Med Assoc J; 1961 Nov; 85(19):1025-31. PubMed ID: 13888218
[No Abstract] [Full Text] [Related]
16. REDUCTION OF SERUM CHOLESTEROL AND LIPIDS BY ETHYL CHLOROPHENOXYISOBUTYRATE.
HELLMAN L; ZUMOFF B; KESSLER G; KARA E; RUBIN IL; ROSENFELD RS
J Atheroscler Res; 1963; 3():454-66. PubMed ID: 14100886
[No Abstract] [Full Text] [Related]
17. EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN NORMAL AND HYPERLIPIDEMIC SUBJECTS.
HOWARD RP; ALAUPOVIC P; BRUSCO OJ; FURMAN RH
J Atheroscler Res; 1963; 3():482-99. PubMed ID: 14100889
[No Abstract] [Full Text] [Related]
18. Thyroid-androgen interrelations and the hypocholesteremic effect of androsterone.
HELLMAN L; BRADLOW HL; ZUMOFF B; FUKUSHIMA DK; GALLAGHER TF
J Clin Endocrinol Metab; 1959 Aug; 19():936-48. PubMed ID: 14400900
[No Abstract] [Full Text] [Related]
19. The effect of clofibrate on thrombocyte adhesivity and some coagulation parameters.
Dybkaer R; Geill T
Gerontol Clin (Basel); 1967; 9(3):157-66. PubMed ID: 6055296
[No Abstract] [Full Text] [Related]
20. [Disorders of purine metabolism in patients with dietary obesity].
Frolova IA; Beiul EA; Popova IuP
Vopr Med Khim; 1985; 31(5):134-8. PubMed ID: 4090360
[No Abstract] [Full Text] [Related]
[Next] [New Search]
